These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26911874)

  • 21. Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.
    Mushtaq S; Ge Y; Livermore DM
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3086-92. PubMed ID: 15273124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Pseudomonas aeruginosa isolates from patients with urinary tract infections during antibiotic therapy.
    Horii T; Muramatsu H; Morita M; Maekawa M
    Microb Drug Resist; 2003; 9(2):223-9. PubMed ID: 12820809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
    Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
    Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.
    Meletis G; Vavatsi N; Exindari M; Protonotariou E; Sianou E; Haitoglou C; Sofianou D; Pournaras S; Diza E
    Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):253-8. PubMed ID: 24062236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of carbapenem-resistant but cephalosporin-susceptible
    Khalili Y; Yekani M; Goli HR; Memar MY
    Acta Microbiol Immunol Hung; 2019 Dec; 66(4):529-540. PubMed ID: 31707785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China.
    Zhang JF; Chen BL; Xin XY; Zhao HB; Wang HY; Song H; Xu ZK
    Microb Drug Resist; 2009 Mar; 15(1):41-5. PubMed ID: 19226194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand.
    Khuntayaporn P; Montakantikul P; Santanirand P; Kiratisin P; Chomnawang MT
    Microbiol Immunol; 2013 Mar; 57(3):170-8. PubMed ID: 23278679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
    Shu JC; Kuo AJ; Su LH; Liu TP; Lee MH; Su IN; Wu TL
    J Antimicrob Chemother; 2017 Sep; 72(9):2489-2495. PubMed ID: 28535274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
    Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.
    Walsh F; Amyes SG
    J Chemother; 2007 Aug; 19(4):376-81. PubMed ID: 17855180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa.
    Hirabayashi A; Kato D; Tomita Y; Iguchi M; Yamada K; Kouyama Y; Morioka H; Tetsuka N; Yagi T
    J Med Microbiol; 2017 Nov; 66(11):1562-1572. PubMed ID: 28984565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem nonsusceptibility with modified
    Choudhury D; Talukdar AD; Choudhury MD; Maurya AP; Chanda DD; Chakravorty A; Bhattacharjee A
    Indian J Med Microbiol; 2017; 35(1):137-139. PubMed ID: 28303836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RELATIVE EXPRESSION OF EFFLUX PUMPS IN MULTI DRUG RESISTANT PSEUDOMONAS AERUGINOSA.
    Azimi L; Namvar AE; Jamali S; Lari AR; Bijari A; Lari AR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):86-90. PubMed ID: 27328522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains.
    Tsai MH; Wu TL; Su LH; Lo WL; Chen CL; Liang YH; Chiu CH
    Int J Antimicrob Agents; 2014 Dec; 44(6):541-5. PubMed ID: 25264129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa.
    Margaret BS; Drusano GL; Standiford HC
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():161-7. PubMed ID: 2509413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First detected OXA-50 carbapenem-resistant clinical isolates
    Petrova A; Feodorova Y; Miteva-Katrandzhieva T; Petrov M; Murdjeva M
    J Med Microbiol; 2019 Dec; 68(12):1723-1731. PubMed ID: 31746726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.